Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin D Supplementation and Solifenacin in Overactive Bladder
IRCT20240504061648N2Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of solifenacin and vitamin d in overactive bladder (OAB), sponsored by Tabriz University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
solifenacinvitamin d
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on IRCT20240504061648N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240504061648N2.